United States Somatostatin Receptor Type 2 Market Report 2017

December 2017 | 97 pages | ID: U505DD782CEEN
QYResearch

Abstracts

In this report, the United States Somatostatin Receptor Type 2 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Somatostatin Receptor Type 2 in these regions, from 2012 to 2022 (forecast).

United States Somatostatin Receptor Type 2 market competition by top manufacturers/players, with Somatostatin Receptor Type 2 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amryt Pharma plc
• Crinetics Pharmaceuticals Inc
• Daewoong Pharmaceutical Co Ltd
• Ipsen SA
• Progenics Pharmaceuticals Inc
• Strongbridge Biopharma plc
• Zucara Therapeutics Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• CRN-00808
• Lanreotide Acetate
• PRL-2903
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hormonal Disorder
• Oncology
• Metabolic Disorder
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Somatostatin Receptor Type 2 Market Report 2017

1 SOMATOSTATIN RECEPTOR TYPE 2 OVERVIEW

1.1 Product Overview and Scope of Somatostatin Receptor Type
1.2 Classification of Somatostatin Receptor Type 2 by Product Category
  1.2.1 United States Somatostatin Receptor Type 2 Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Somatostatin Receptor Type 2 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 CRN-00808
  1.2.4 Lanreotide Acetate
  1.2.5 PRL-2903
  1.2.6 Others
1.3 United States Somatostatin Receptor Type 2 Market by Application/End Users
  1.3.1 United States Somatostatin Receptor Type 2 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hormonal Disorder
  1.3.3 Oncology
  1.3.4 Metabolic Disorder
  1.3.5 Others
1.4 United States Somatostatin Receptor Type 2 Market by Region
  1.4.1 United States Somatostatin Receptor Type 2 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
  1.4.3 Southwest Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
  1.4.5 New England Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
  1.4.6 The South Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
  1.4.7 The Midwest Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Somatostatin Receptor Type 2 (2012-2022)
  1.5.1 United States Somatostatin Receptor Type 2 Sales and Growth Rate (2012-2022)
  1.5.2 United States Somatostatin Receptor Type 2 Revenue and Growth Rate (2012-2022)

2 UNITED STATES SOMATOSTATIN RECEPTOR TYPE 2 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Somatostatin Receptor Type 2 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Somatostatin Receptor Type 2 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Somatostatin Receptor Type 2 Average Price by Players/Suppliers (2012-2017)
2.4 United States Somatostatin Receptor Type 2 Market Competitive Situation and Trends
  2.4.1 United States Somatostatin Receptor Type 2 Market Concentration Rate
  2.4.2 United States Somatostatin Receptor Type 2 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Somatostatin Receptor Type 2 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SOMATOSTATIN RECEPTOR TYPE 2 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Somatostatin Receptor Type 2 Sales and Market Share by Region (2012-2017)
3.2 United States Somatostatin Receptor Type 2 Revenue and Market Share by Region (2012-2017)
3.3 United States Somatostatin Receptor Type 2 Price by Region (2012-2017)

4 UNITED STATES SOMATOSTATIN RECEPTOR TYPE 2 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Somatostatin Receptor Type 2 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Somatostatin Receptor Type 2 Revenue and Market Share by Type (2012-2017)
4.3 United States Somatostatin Receptor Type 2 Price by Type (2012-2017)
4.4 United States Somatostatin Receptor Type 2 Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SOMATOSTATIN RECEPTOR TYPE 2 SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Somatostatin Receptor Type 2 Sales and Market Share by Application (2012-2017)
5.2 United States Somatostatin Receptor Type 2 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SOMATOSTATIN RECEPTOR TYPE 2 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Amryt Pharma plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Crinetics Pharmaceuticals Inc
  6.2.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Daewoong Pharmaceutical Co Ltd
  6.3.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Ipsen SA
  6.4.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ipsen SA Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Progenics Pharmaceuticals Inc
  6.5.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Strongbridge Biopharma plc
  6.6.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Zucara Therapeutics Inc
  6.7.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 SOMATOSTATIN RECEPTOR TYPE 2 MANUFACTURING COST ANALYSIS

7.1 Somatostatin Receptor Type 2 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Somatostatin Receptor Type

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Somatostatin Receptor Type 2 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Somatostatin Receptor Type 2 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SOMATOSTATIN RECEPTOR TYPE 2 MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Somatostatin Receptor Type 2 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Somatostatin Receptor Type 2 Sales Volume Forecast by Type (2017-2022)
11.3 United States Somatostatin Receptor Type 2 Sales Volume Forecast by Application (2017-2022)
11.4 United States Somatostatin Receptor Type 2 Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Somatostatin Receptor Type
Figure United States Somatostatin Receptor Type 2 Market Size (K Pcs) by Type (2012-2022)
Figure United States Somatostatin Receptor Type 2 Sales Volume Market Share by Type (Product Category) in 2016
Figure CRN-00808 Product Picture
Figure Lanreotide Acetate Product Picture
Figure PRL-2903 Product Picture
Figure Others Product Picture
Figure United States Somatostatin Receptor Type 2 Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Somatostatin Receptor Type 2 by Application in 2016
Figure Hormonal Disorder Examples
Table Key Downstream Customer in Hormonal Disorder
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Metabolic Disorder Examples
Table Key Downstream Customer in Metabolic Disorder
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Somatostatin Receptor Type 2 Market Size (Million USD) by Region (2012-2022)
Figure The West Somatostatin Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Somatostatin Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Somatostatin Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Somatostatin Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Somatostatin Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Somatostatin Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Somatostatin Receptor Type 2 Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Somatostatin Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Somatostatin Receptor Type 2 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Somatostatin Receptor Type 2 Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Somatostatin Receptor Type 2 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Somatostatin Receptor Type 2 Sales Share by Players/Suppliers
Figure 2017 United States Somatostatin Receptor Type 2 Sales Share by Players/Suppliers
Figure United States Somatostatin Receptor Type 2 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Somatostatin Receptor Type 2 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Somatostatin Receptor Type 2 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Somatostatin Receptor Type 2 Revenue Share by Players/Suppliers
Figure 2017 United States Somatostatin Receptor Type 2 Revenue Share by Players/Suppliers
Table United States Market Somatostatin Receptor Type 2 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Somatostatin Receptor Type 2 Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Somatostatin Receptor Type 2 Market Share of Top 3 Players/Suppliers
Figure United States Somatostatin Receptor Type 2 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Somatostatin Receptor Type 2 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Somatostatin Receptor Type 2 Product Category
Table United States Somatostatin Receptor Type 2 Sales (K Pcs) by Region (2012-2017)
Table United States Somatostatin Receptor Type 2 Sales Share by Region (2012-2017)
Figure United States Somatostatin Receptor Type 2 Sales Share by Region (2012-2017)
Figure United States Somatostatin Receptor Type 2 Sales Market Share by Region in 2016
Table United States Somatostatin Receptor Type 2 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Somatostatin Receptor Type 2 Revenue Share by Region (2012-2017)
Figure United States Somatostatin Receptor Type 2 Revenue Market Share by Region (2012-2017)
Figure United States Somatostatin Receptor Type 2 Revenue Market Share by Region in 2016
Table United States Somatostatin Receptor Type 2 Price (USD/Pcs) by Region (2012-2017)
Table United States Somatostatin Receptor Type 2 Sales (K Pcs) by Type (2012-2017)
Table United States Somatostatin Receptor Type 2 Sales Share by Type (2012-2017)
Figure United States Somatostatin Receptor Type 2 Sales Share by Type (2012-2017)
Figure United States Somatostatin Receptor Type 2 Sales Market Share by Type in 2016
Table United States Somatostatin Receptor Type 2 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Somatostatin Receptor Type 2 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Somatostatin Receptor Type 2 by Type (2012-2017)
Figure Revenue Market Share of Somatostatin Receptor Type 2 by Type in 2016
Table United States Somatostatin Receptor Type 2 Price (USD/Pcs) by Types (2012-2017)
Figure United States Somatostatin Receptor Type 2 Sales Growth Rate by Type (2012-2017)
Table United States Somatostatin Receptor Type 2 Sales (K Pcs) by Application (2012-2017)
Table United States Somatostatin Receptor Type 2 Sales Market Share by Application (2012-2017)
Figure United States Somatostatin Receptor Type 2 Sales Market Share by Application (2012-2017)
Figure United States Somatostatin Receptor Type 2 Sales Market Share by Application in 2016
Table United States Somatostatin Receptor Type 2 Sales Growth Rate by Application (2012-2017)
Figure United States Somatostatin Receptor Type 2 Sales Growth Rate by Application (2012-2017)
Table Amryt Pharma plc Basic Information List
Table Amryt Pharma plc Somatostatin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amryt Pharma plc Somatostatin Receptor Type 2 Sales Growth Rate (2012-2017)
Figure Amryt Pharma plc Somatostatin Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure Amryt Pharma plc Somatostatin Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table Crinetics Pharmaceuticals Inc Basic Information List
Table Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales Growth Rate (2012-2017)
Figure Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table Daewoong Pharmaceutical Co Ltd Basic Information List
Table Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales Growth Rate (2012-2017)
Figure Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table Ipsen SA Basic Information List
Table Ipsen SA Somatostatin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ipsen SA Somatostatin Receptor Type 2 Sales Growth Rate (2012-2017)
Figure Ipsen SA Somatostatin Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure Ipsen SA Somatostatin Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table Progenics Pharmaceuticals Inc Basic Information List
Table Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales Growth Rate (2012-2017)
Figure Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table Strongbridge Biopharma plc Basic Information List
Table Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales Growth Rate (2012-2017)
Figure Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure Strongbridge Biopharma plc Somatostatin Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table Zucara Therapeutics Inc Basic Information List
Table Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales Growth Rate (2012-2017)
Figure Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure Zucara Therapeutics Inc Somatostatin Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Somatostatin Receptor Type
Figure Manufacturing Process Analysis of Somatostatin Receptor Type
Figure Somatostatin Receptor Type 2 Industrial Chain Analysis
Table Raw Materials Sources of Somatostatin Receptor Type 2 Major Players/Suppliers in 2016
Table Major Buyers of Somatostatin Receptor Type
Table Distributors/Traders List
Figure United States Somatostatin Receptor Type 2 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Somatostatin Receptor Type 2 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Somatostatin Receptor Type 2 Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Somatostatin Receptor Type 2 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Somatostatin Receptor Type 2 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Somatostatin Receptor Type 2 Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Somatostatin Receptor Type 2 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Somatostatin Receptor Type 2 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Somatostatin Receptor Type 2 Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Somatostatin Receptor Type 2 Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Somatostatin Receptor Type 2 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Somatostatin Receptor Type 2 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Somatostatin Receptor Type 2 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources